Objective:To systematically review the current implementation status of nurses’non-pharmacological prescription authority and analyze the barriers encountered during its implementation in China,providing countermeasu...Objective:To systematically review the current implementation status of nurses’non-pharmacological prescription authority and analyze the barriers encountered during its implementation in China,providing countermeasures and references for promoting the standardized implementation of nurses’non-pharmacological prescription authority.Methods:A secondary analysis of literature was conducted to systematically search for domestic and international literature related to nurses’non-pharmacological prescription authority.Meta-analysis was performed on eligible literature to evaluate the implementation effects.Simultaneously,semi-structured in-depth interviews were conducted with healthcare workers,patients,and policymakers.Content analysis was used to organize the interview data and extract core issues and barriers.Results:A total of 46 international articles were included in the Meta-analysis,which revealed that the implementation of nurses’non-pharmacological prescription authority significantly improved patients’health management outcomes,enhanced healthcare service efficiency,and increased patient satisfaction.Conclusion:The implementation of nurses’non-pharmacological prescription authority has demonstrated significant positive effects.However,China faces multiple barriers in its advancement,necessitating efforts in optimizing policy systems,constructing collaborative models,strengthening professional skills training,and improving social awareness to guide the scientific and rational implementation of nurses’non-pharmacological prescription authority.展开更多
Objective:To analyze the application value of prescription management of traditional Chinese medicine formula granules in reducing unreasonable prescriptions.Methods:From January to June 2024,before improving prescrip...Objective:To analyze the application value of prescription management of traditional Chinese medicine formula granules in reducing unreasonable prescriptions.Methods:From January to June 2024,before improving prescription management strategies,118 patients treated with traditional Chinese medicine formula granules were included in the control group.From July to December 2024,after improving prescription management strategies,118 patients treated with traditional Chinese medicine formula granules were included in the observation group.The unqualified prescription rate,incidence of adverse reactions,complaint rate,and satisfaction were compared.Results:The unqualified prescription rate of traditional Chinese medicine formula granules in the observation group was lower than that in the control group(P<0.05);the incidence of adverse reactions and patient complaint rate of traditional Chinese medicine formula granules in the observation group were lower than those in the control group(P<0.05);the satisfaction of traditional Chinese medicine formula granules in the observation group was higher than that in the control group(P<0.05).Conclusion:Improving the prescription management strategy of traditional Chinese medicine formula granules can reduce the unqualified prescription rate and the incidence of adverse drug reactions,reduce patient complaints,and is conducive to improving patient satisfaction.展开更多
Objective Randomized controlled trials(RCTs)of Chinese patent medicines and classic tra-ditional Chinese medicine prescriptions were systematically reviewed from both Chinese and English journals published in 2023.A p...Objective Randomized controlled trials(RCTs)of Chinese patent medicines and classic tra-ditional Chinese medicine prescriptions were systematically reviewed from both Chinese and English journals published in 2023.A preliminary summary and evaluation were conducted on the generation and translation of clinical evidence for these treatments.This analysis aims to inform future research on clinical efficacy evaluation and guide the rational application of evidence.Methods RCTs of Chinese patent medicines and classic traditional Chinese prescriptions published in 2023 were comprehensively retrieved from the Artificial Intelligence Clinical Evi-dence Database for Chinese Patent Medicine(AICED-CPM),with supplementary searches conducted in China National Knowledge Infrastructure(CNKI),Wanfang Data,Chinese Sci-ence and Technology Journal Database(VIP),Chinese Biomedical Literature Database(SinoMed),Cochrane Library,PubMed,Embase,and Web of Science.The study characteris-tics and methodological quality of these RCTs were systematically analyzed and evaluated.Results A total of 1443 RCTs of Chinese patent medicines were included,comprising 1399 Chinese articles and 44 English articles.Additionally,334 RCTs of classic traditional Chinese medicine prescriptions were found,with 331 published in Chinese and 3 in English.196567 participants were included,covering 585 types of Chinese patent medicines(487 oral,61 in-jectable,and 37 topical)and 179 classic traditional Chinese medicine prescriptions.The in-volved studies encompassed 22 types of diseases,with research primarily focusing on dis-eases of the circulatory system,the respiratory system,and the genitourinary system.The sample sizes ranged from 18 to 3777 participants,and most studies were conducted at a sin-gle center.Methodologically,the implementation of allocation concealment and blinding re-mained insufficiently emphasized.Conclusion Overall,compared with 2022,both the number of RCT publications and their methodological quality have improved in 2023,with heightened attention to research on diseases of the genitourinary system.However,quality control and standardized management in the design and implementation processes still require enhancement to produce more high-quality clinical evidence and accelerate the translation and application of this evidence.展开更多
OBJECTIVE:To investigate the protective effects of Guilong prescription(归龙方,GL)on chronic prostatitis(CP)and unravel the underlying mechanisms of its pharmacological effects.METHODS:The composition of GL was determ...OBJECTIVE:To investigate the protective effects of Guilong prescription(归龙方,GL)on chronic prostatitis(CP)and unravel the underlying mechanisms of its pharmacological effects.METHODS:The composition of GL was determined via linear ion trap/electrostatic field orbital trap tandem highresolution mass spectrometry,and the identified compounds were performed network pharmacological analysis to predict possible pathways of the effects of GL on CP.A CP rat model was established by carrageenan,and rats were randomly assigned into a Control group,Sham group,CP group,GL low dose(3.5 g/kg)group,GL medium dose(7 g/kg)group,and GL high dose(14 g/kg)group.Hematoxylin-eosin staining of the prostate,and prostate blood-perfusion measured by laser speckle contrast analysis were used to evaluate the efficacy of GL.Expression of intercellular cell adhesion molecule-1(ICAM-1)and induce nitric oxide synthase(i NOS)were determined by immunohistochemistry,and the content of interferon-γ(IFN-γ),interleukin-1β(IL-1β),interleukin-4(IL-4),interleukin-10(IL-10),chemokine ligand 1(CXCL1)and tumor necrosis factor-α(TNF-α)were determined by electro-chemiluminescence assays.The expression of p38 mitogen-activated protein kinase(p38 MAPK),phosphatidylinositol 3-kinase(PI3K),ribosomeassociated complex-alpha serine/threonine-protein kinase(Akt),nuclear factor-κ-gene binding p65(NF-κB p65),inhibitor of NF-κB-α(IκBα),glycogen synthase kinase-3β(GSK-3β),and their phosphorylated forms were tested by Western blot.RESULTS:In GL,a total of 48 compounds were identified,including 14 flavonoids,14 alkaloids,11 carboxylic acids,4 lactones,2 glycosides,2 terpenoids and 1 aldehyde.Network pharmacological analysis suggested that the mechanism of GL may be related to PI3K-Akt signaling pathway and cytokine expression.After treatment with GL,inflammatory pathological changes in the prostate of rats were significantly improved,and blood perfusion of the prostate was significantly decreased.GL reduced the expression of IFN-γ,CXCL1,TNF-α,IL-1β,i NOS,ICAM-1,p38 MAPK,p-p38 MAPK,PI3K,p-PI3K,NF-κB,p-NF-κB,IκBα,p-IκBα,GSK-3β,p-GSK-3β,p-Akt in CP rats,and increased the expression of IL-4 and IL-10 in CP rats.CONCLUSION:The chemical compositions of GL were first identified.GL can improve pathological changes in the prostate and recover the prostate blood perfusion of CP rats.The possible mechanisms of GL on CP involve increasing the expression of anti-inflammatory cytokines IL-4 and IL-10,inhibiting pro-inflammatory cytokines TNF-α,IL-1β,and IFN-γ,and down regulating the expression of CXCL1,i NOS,and ICAM-1 via inhibiting PI3K-Akt and NF-κB signaling pathway.展开更多
OBJECTIVE:To determine the effect of Traditional Chinese Medicine(TCM)Fuzheng Xuanfei Huashi prescription(扶正宣肺化湿方,FZXF)on lipopolysaccharide(LPS)-induced pneumonia in mice and identify the mechanism of FZXF in ...OBJECTIVE:To determine the effect of Traditional Chinese Medicine(TCM)Fuzheng Xuanfei Huashi prescription(扶正宣肺化湿方,FZXF)on lipopolysaccharide(LPS)-induced pneumonia in mice and identify the mechanism of FZXF in the treatment of LPS-induced lung inflammation.METHODS:The pneumonia model was established by intraperitoneal injection of 5 mg/kg LPS in mice.Cytokines were detected by enzyme-linked immuneosorbent assay(ELISA),macrophages in lung tissue were determined by immunofluorescence,and pathwayrelated data were determined by quantitative real-time polymerase chain reaction(qPCR)and Western blot.RESULTS:The liver,thymus,and spleen index values and the levels of aspartate aminotransferase(AST)and alanine aminotransferase(ALT)obviously increased in LPS-treated mice.FZXF decreased the white blood cell count and reduced the increase in the lung wet weight/dry weight ratio caused by LPS.The hematoxylin-eosin staining result showed that FZXF could maintain the integrity of lung tissue structure,alleviate interstitial oedema and alveolar wall thickening,and reduce inflammatory cell infiltration.Moreover,FZXF markedly reduced the expression of proinflammatory cytokines.FZXF also significantly reduced LPS-induced malondialdehyde production and increased superoxide dismutase level in the lung.By immunofluorescence,we found that FZXF could reduce macrophage infiltration.The mRNA expression levels of cyclooxygenase-2(COX-2),prostaglandin E2(PGE2),toll-like receptor 4(TLR4)and nuclear transcription factorκB(NF-κB)in the lung tissue of mice were decreased by treatment with FZXF.In addition,FZXF inhibited the protein expression of TLR4,p-p65 and COX-2.These results indicated that FZXF could inhibit the inflammatory response of LPS induced cytokine storm in mice through TLR4/NF-κB and COX-2/PGE2 signaling pathway.CONCLUSION:These findings were suggested that FZXF prescription suppresses inflammation in LPSinduced pneumonia in mice via TLR4/NF-κB and COX-2/PGE2 pathway.展开更多
Objective To configure the complex traditional Chinese medicine(TCM)prescription using digit topology circle and to derive digit topology circle.Methods The basic digit topology circles were constructed.Different digi...Objective To configure the complex traditional Chinese medicine(TCM)prescription using digit topology circle and to derive digit topology circle.Methods The basic digit topology circles were constructed.Different digit topology circles were derived using basic digit topology circle,the character strings,and the digit groups.Different digit topology circles with ternary Chinese medicine were derived by adding ternary Chinese medicine into digit topology circles.The valuable TCM prescriptions were configured using the derived digit topology circles.Results Nine simple basic digit topology circles were constructed from the character strings.Multiple digit topology circles and some digit topology circles with ternary Chinese medicine were derived using basic digit topology circles,the character strings,and the digit groups.Four complex TCM prescriptions were configured using four derived digit topology circles digit topology circles,respectively.Conclusion The digit topology circles can be used to configure some existing TCM prescriptions and many novel TCM prescriptions.It has been verified that some existing TCM prescriptions have been used successfully to treat patients with diseases.Some novel valuable TCM prescriptions configured by digit topology circles may be used to treat patients with diseases.展开更多
[Objectives]To discuss the curative effect of the external application of self-prepared Chinese prescription decoction combined with gabapentin and cotton moxibustion on postherpetic neuralgia(PHN)and analyze its mech...[Objectives]To discuss the curative effect of the external application of self-prepared Chinese prescription decoction combined with gabapentin and cotton moxibustion on postherpetic neuralgia(PHN)and analyze its mechanism.[Methods]96 patients with PHN were divided into the control group(group A)and observation group(group B)(n=48).In group A,the patients were given gabapentin orally and treated by cotton moxibustion.In group B,the patients were treated by the external application of self-prepared Chinese prescription decoction on the basis of the above basic treatment.The total effective rate,apparent time and recurrence rate of the two groups were compared.[Results]The cure rate(72.91%)and total effective rate(95.83%)of patients in group B were higher than those in group A(54.16%,83.33%).The average apparent time[(5.79±1.40)d]and recurrence rate(5.97%)of patients in group B were significantly lower than those in group A[(7.03±4.37)d,10.45%],and the difference between the two groups was statistically significant(P<0.05).[Conclusions]The external application of self-prepared Chinese prescription decoction combined with gabapentin and cotton moxibustion therapy had a significant curative effect and low recurrence rate.展开更多
Traditional Chinese medicine(TCM)exerts integrative effects on complex diseases owing to the characteristics of multiple components with multiple targets.However,the syndrome-based system of diagnosis and treatment in...Traditional Chinese medicine(TCM)exerts integrative effects on complex diseases owing to the characteristics of multiple components with multiple targets.However,the syndrome-based system of diagnosis and treatment in TCM can easily lead to bias because of varying medication preferences among physicians,which has been a major challenge in the global acceptance and application of TCM.Therefore,a standardized TCM prescription system needs to be explored to promote its clinical application.In this study,we first developed a gradient weighted disease-target-herbal ingredient-herb network to aid TCM formulation.We tested its efficacy against intracerebral hemorrhage(ICH).First,the top 100 ICH targets in the GeneCards database were screened according to their relevance scores.Then,SymMap and Traditional Chinese Medicine Systems Pharmacology(TCMSP)databases were applied to find out the target-related ingredients and ingredient-containing herbs,respectively.The relevance of the resulting ingredients and herbs to ICH was determined by adding the relevance scores of the corresponding targets.The top five ICH therapeutic herbs were combined to form a tailored TCM prescriptions.The absorbed components in the serum were detected.In a mouse model of ICH,the new prescription exerted multifaceted effects,including improved neurological function,as well as attenuated neuronal damage,cell apoptosis,vascular leakage,and neuroinflammation.These effects matched well with the core pathological changes in ICH.The multi-targets-directed gradient-weighting strategy presents a promising avenue for tailoring precise,multipronged,unbiased,and standardized TCM prescriptions for complex diseases.This study provides a paradigm for advanced achievements-driven modern innovation in TCM concepts.展开更多
Objective:To explore the intervention value of the medical institution prescription review mechanism on the rationality of Western medicine use.Methods:A total of 159 patients(with 159 western medicine prescriptions)a...Objective:To explore the intervention value of the medical institution prescription review mechanism on the rationality of Western medicine use.Methods:A total of 159 patients(with 159 western medicine prescriptions)admitted to the hospital from January 2023 to December 2024 were selected and divided into an observation group(n=80,adopting the medical institution prescription review mechanism)and a control group(n=79,without prescription review)based on the random number table method.A comparative analysis was conducted on the work quality of medical personnel,irrational prescription drug use,and prescription drug dispensing situations.Results:The work quality of medical personnel in the observation group was significantly better than that in the control group(P<0.05).The incidence of irrational prescription drug use in the observation group(22.50%)was significantly higher than that in the control group(7.59%)(P<0.05).The observation group had fewer types of prescribed drugs,lower usage rates of injections and antibiotics,and a significantly higher usage rate of national essential drugs compared to the control group(P<0.05).Conclusion:The prescription review mechanism can significantly improve the work quality of medical personnel,increase the detection rate of irrational drug use,reduce the types of prescription drugs and the use of injections and antibiotics,and promote the standardized application of national essential drugs,which has important intervention value.展开更多
OBJECTIVE:To evaluate the effect of Yiqi Liangxue Shengji prescription(益气凉血生肌方,YQLXSJ)on cardiac function and outcomes in acute myocardial infarction(AMI)patients with myocardial ischemiareperfusion injury(MIRI...OBJECTIVE:To evaluate the effect of Yiqi Liangxue Shengji prescription(益气凉血生肌方,YQLXSJ)on cardiac function and outcomes in acute myocardial infarction(AMI)patients with myocardial ischemiareperfusion injury(MIRI)and to determine its clinical efficacy.METHODS:This prospective,randomized,double-blind,placebo-controlled trial enrolled hospitalized patients with AMI who underwent percutaneous coronary intervention and experienced MIRI either intraoperatively or postoperatively.Participants were randomly allocated to the treatment group,which received YQLXSJ,or the control group,which received a placebo,concurrent with standard Western Medicine therapy.The intervention period lasted 8 weeks.The primary outcome measure was left ventricular ejection fraction(LVEF),determined by echocardiography.Secondary outcomes included Nterminal pro brain natriuretic peptide(NT-pro BNP)and cardiac troponin I(cTnI)levels,left ventricular internal diameter,major adverse cardiovascular events(MACE),angina pectoris scores,and Chinese medicine evidence scores.RESULTS:Following 8 weeks of intervention,the treatment group demonstrated a significant increase in LVEF and a marked reduction in NT-pro BNP when compared to the control group.There was also a significant decrease in peak cTnI levels,Chinese medicine evidence scores,and angina pectoris scores.The control group's left ventricular end-systolic diameter(LVESD)significantly increased compared to baseline after 8 weeks(P<0.05),whereas the treatment group's LVESD showed no significant change from baseline(P>0.05).Although the treatment group showed a downward trend in MACE incidence compared to the control group,this difference was not statistically significant(P>0.05).CONCLUSIONS:This study demonstrated that the addition of YQLXSJ to standard therapy can improve cardiac function and alleviate clinical symptoms in AMI patients with MIRI,and also showed a potential to mitigate the incidence of MACE.Furthermore,YQLXSJ displayed a favorable safety profile in clinical application.展开更多
BACKGROUND Xietu Hemu prescription(XHP),a Chinese patent formula,is optimized based on the theory of“phlegm-dampness”and has been clinically validated to effectively combat metabolic dysfunction-associated steatotic...BACKGROUND Xietu Hemu prescription(XHP),a Chinese patent formula,is optimized based on the theory of“phlegm-dampness”and has been clinically validated to effectively combat metabolic dysfunction-associated steatotic liver disease(MASLD).It notably reduces visceral fat and body mass index.However,the molecular mechanisms underlying its regulation of lipid metabolism homeostasis remain unexplored.AIM To elucidate the mechanisms by which XHP inhibits adipocyte differentiation and maintains lipid metabolism homeostasis.METHODS The therapeutic efficacy of XHP in metabolic-related disorders was analyzed using HepG2 cells and 3T3-L1 cells,along with transcriptomics to assess gene expression alterations during white adipogenesis.The primary metabolites of XHP were identified through ultra-performance liquid chromatography,and metabolic pathways were examined via serum metabolomics.Network analysis was employed to predict therapeutic targets.The accumulation of lipid droplets and the expression of associated proteins were confirmed using oil red O staining and Western blotting,respectively.Molecular docking was utilized to identify core targets and signaling pathways,which were substantiated through immunofluorescence and siRNA interference.RESULTS XHP-containing serum(XHPS)significantly inhibited the transformation of normal HepG2 cells into fatty liver cells.Concurrently,the treatment suppressed the differentiation of 3T3-L1 cells,reduced lipid droplet accumulation and total cholesterol/triglyceride levels,and downregulated the expression of PPARγ,C/EBPα,and FABP4.Through transcriptomics and network pharmacological intersectionality analyses,24 core targets were identified,predominantly enriched in the AMPK signaling pathway.Molecular docking validated the strong binding affinity of XHP metabolites to targets such as leptin(-11.3 kcal/mol)and ADIPOQ(-9.4 kcal/mol).ELISA results indicated that XHPS augmented leptin autocrine secretion,thereby activating the AMPK signaling pathway(P<0.05).Conversely,LEPR knockdown negated this effect(P<0.05).CONCLUSION XHP effectively inhibits adipogenesis and enhances lipid metabolism homeostasis through the LEP/AMPK/PPARγpathway,presenting a promising multi-target therapeutic strategy for MASLD by mitigating lipotoxicity.展开更多
OBJECTIVE:To identify the main active ingredients of Improved Yupingfeng Powder prescription(IYPFP,玉屏风散加味)and investigate its anti-inflammatory effects and underlying mechanisms in ovalbumins(OVA)-induced allerg...OBJECTIVE:To identify the main active ingredients of Improved Yupingfeng Powder prescription(IYPFP,玉屏风散加味)and investigate its anti-inflammatory effects and underlying mechanisms in ovalbumins(OVA)-induced allergic rhinitis(AR)in mice.METHODS:Bagg Albino/substrain mice were sensitized with OVA emulsified in aluminum hydroxide adjuvant,followed by intranasal challenge to establish AR models.Treatment groups received IYPFP(1.5 or 4.5 g/kg)via daily gavage for 14 d.The nasal mucosa tissues were collected for pathological observation.The expression of OVA-specific immunoglobulin E(Ig E),histamine,and interleukin-33(IL-33)was detected by enzyme-linked immunosorbent assay.IL-5,IL-13,IL-33,suppression of tumorigenicity 2(ST2),tumor necrosis factor-α(TNF-α)and interferon-γ(IFN-γ)in the nasal mucosa and lung were detected by quantitative polymerase chain reaction and Western blot.High performance liquid chromatography and ultra-high performance liquid chromatography quadrupole exactive orbitrap mass spectrometry were used to detect the chemical fingerprints of IYPFP,and the chemical compositions of plasma from rats treated with IYPFP at 0.5,1,1.5,2,3,4 and 6 h,respectively.Virtual screening of bioactive compounds was conducted through molecular docking targeting IL-33/ST2 pathway proteins.RESULTS:Eight chemical compounds of IYPFP were accurately identified,they are prim-O-glucosylcimifugin(peak 2),calycosin-7-O-β-D-glucoside(peak 4),cimifugin(peak 5),5-O-methylvisammioside(peak 6),sec-Oglucosylhamaudol(peak 12),calycosin(peak 15),formononetin(peak 19),and magnolin(peak 21).Compared with the OVA model group,IYPFP alleviated the nasal symptoms,improved nasal mucosal injury and downregulated the levels of OVA-specific Ig E,histamine and IL-33.Additionally,IYPFP reduced the levels of IL-5,IL-13,TNF-α,IL-33,and ST2 in the lungs,but upregulated IFN-γ.Molecular docking confirmed that eight representative compounds of IYPFP had good binding properties with IL-5,IL-13,IFN-γ,histamine,IL-33 and ST2,and were able to inhibit the activation of the IL33/ST2 inflammatory pathway.CONCLUSION:This study demonstrates that IYPFP ameliorates AR by modulating IL-33/ST2 pathway which provides a theoretical basis for the clinical treatment of patients with AR.展开更多
Objectives:To propose a new idea of“lung ventilation and Qi regulation”for preventing and treating lung cancer,and to summarize the corresponding Tongfei Huajie prescription,as a systematic theoretical and practical...Objectives:To propose a new idea of“lung ventilation and Qi regulation”for preventing and treating lung cancer,and to summarize the corresponding Tongfei Huajie prescription,as a systematic theoretical and practical innovation.Methods:Based on the etiology and pathogenesis of lung cancer,the anatomy,physiology and pathology of the lung,and inspired by the ancient“Tuoyue”(bellows)theory,this study combined the clinical observation of ventilation issues in lung cancer patients.The Tongfei Huajie prescription was formulated following the classic principle of monarch(Jun),minister(Chen),assistant(Zuo),and guide(Shi),and was interpreted with modern pharmacological research.Results:A novel therapeutic concept of“lung ventilation and Qi regulation”was proposed.The corresponding Tongfei Huajie prescription was developed,which has the effects of ventilating the lung,expelling phlegm dampness,tonifying Qi,tonifying the kidney and spleen for lung health,soothing the liver and descending lung Qi,and clearing the heart and moistening the lung.Clinical application has achieved obvious curative effect.Conclusions:This work presents a systematic summary of the innovation in“theory,method,formula and herb”for lung cancer treatment,demonstrating the advantages of Traditional Chinese Medicine in this field.展开更多
[Objectives]This study was conducted to analyze the medication laws of traditional Chinese medicine prescriptions for the treatment of spleen-deficiency irritable bowel syndrome in Guanling Autonomous County Hospital ...[Objectives]This study was conducted to analyze the medication laws of traditional Chinese medicine prescriptions for the treatment of spleen-deficiency irritable bowel syndrome in Guanling Autonomous County Hospital of Traditional Chinese Medicine.[Methods]Prescriptions for the treatment of spleen-deficiency irritable bowel syndrome(IBS)were retrieved from the TCM family of the hospital,traditional Chinese medical doctor Wu Zhongli,in the period from November 2023 to April 2024.Microsoft Excel 2007 was employed to set up an information table of TCM prescriptions,and the age,gender,herbal properties,efficacy categories and the frequency of use were analyzed to explore the medication laws of TCM in the hospital for the treatment of spleen-deficiency irritable bowel syndrome.[Results]Among the 259 TCM prescriptions included,152 kinds of TCM decoction pieces were used.The decoction pieces were mainly warm in nature,and decoction pieces cold in nature took the second place.The flavors of the herbs were mostly sweet,bitter and pungent.Most of them were attributive to the spleen,stomach meridian and lung meridians,and the herbs were mainly used for tonifying deficiency and regulating qi.The herbs with higher frequency of use included Radix Glycyrrhiza,Pericarpium Citri Reticulatae,poria,and Angelicae Sinensis Radix,the main effects of which are replenishing qi to invigorate the spleen,activating qi and eliminating phlegm,clearing damp and promoting diuresis,and relaxing bowel.[Conclusions]Chinese medicine treatment of IBS with spleen deficiency in hospitals is mainly based on replenishing qi to invigorate the spleen,activating qi and eliminating phlegm,clearing damp and promoting diuresis,and relaxing bowel,and Xiangsha Liujunzi Decoction is commonly used in clinical treatment based on syndrome differentiation with modifications.展开更多
The quality of traditional Chinese medicine(TCM)prescriptions(TCMPs)is critical to clinical efficacy;however,evaluating their consistency and identifying sources of variability remain challenging.This study proposes a...The quality of traditional Chinese medicine(TCM)prescriptions(TCMPs)is critical to clinical efficacy;however,evaluating their consistency and identifying sources of variability remain challenging.This study proposes an integrated strategy to assess the quality of 100 widely sold TCMPs.A"one-for-all"chromatographic method was employed to analyze 645 sample batches.This large-scale data collection enabled statistical evaluations,such as hierarchical cluster analysis(HCA)and similarity heatmap,to identify quality inconsistencies.The introduction of a TCM-specific mass spectrometry(MS)database allowed for rapid,automated annotation of chemicals across 100 prescriptions and facilitated the tracing of raw material sources.Results indicate that 19%of prescriptions exhibited chemical inconsistencies,which are associated with high market value,low pricing,and substantial price disparities.The MS database allowed rapid annotation of 761 and 673 compounds in positive and negative modes,respec-tively,in 100 TCMPs,with 73 prescriptions reported for the first time.The tracing efforts succeeded in identifying>40%of the raw material sources for 51 prescriptions.P93(Yinianjin(YNJ))is a case in which the chromatographic profiles from three manufacturers displayed inconsistencies.Analysis using the database traced divergent peaks to Rhei Radix et Rhizoma(RRER).Verification with self-prepared samples confirmed that manufacturers utilized three distinct botanical sources.This integrated strategy provides a scalable framework for quality control in TCMPs.展开更多
Irrational drug use and prescription safety are pressing global concerns.The World Health Organization estimated that over half of all prescriptions worldwide contain errors,leading to substantial harm[1,2].In China,p...Irrational drug use and prescription safety are pressing global concerns.The World Health Organization estimated that over half of all prescriptions worldwide contain errors,leading to substantial harm[1,2].In China,prescription errors occur at a rate of 32%,and improper medication use is reported in over 70%of households[3,4].Vulnerable populations,including children(16.7%)and older adults(30.4%),are particularly affected[5].展开更多
This article provides a comprehensive review of the advancements in the application of artificial intelligence(AI)technology in the modernization of traditional Chinese medicine(TCM)compound prescriptions,and emphasiz...This article provides a comprehensive review of the advancements in the application of artificial intelligence(AI)technology in the modernization of traditional Chinese medicine(TCM)compound prescriptions,and emphasizes recent research developments,including intelligent design,prediction of mechanisms of action,and precise application of TCM compound prescriptions.The integration of multi-omics data,deep learning algorithms,and knowledge graph technologies has established novel technical avenues for the modernization research of TCM.This study systematically analyzes the advantages and challenges associated with AI technologies in the research of TCM compound prescriptions,highlighting issues such as data heterogeneity,limited interpretability of AI models,and the absence of standardized procedures.Furthermore,this article examines the prospective developmental trajectories within this field,highlighting the importance of synergistic collaboration between AI and traditional pharmacology to improve the clinical applicability and effectiveness of TCM.The objective is to offer valuable insights into the modernization of TCM driven by AI and to stimulate further research in this area.展开更多
OBJECTIVES To examine 5-year trends and variations in dual antiplatelet therapy(DAPT)prescription among multiethnic Malaysian patients aged 60 years and older.METHODS Using the Malaysian National Cardiovascular Diseas...OBJECTIVES To examine 5-year trends and variations in dual antiplatelet therapy(DAPT)prescription among multiethnic Malaysian patients aged 60 years and older.METHODS Using the Malaysian National Cardiovascular Disease-Acute Coronary Syndrome(NCVD-ACS)registry,DAPT 5-year temporal trends prescribing patterns at discharge were examined.Multivariate logistic regression was used to calculate the adjusted odds ratio(aOR)of DAPT prescription.The 1-year all-cause mortality by Cox proportional hazard regression model(adjusted hazard ratio,aHR)using inverse proportional weighting covariates adjustment was performed to assess DAPT prognostic impacts.RESULTS Data of patients aged 60 years and older were extracted from 2013 to 2017(n=3718,mean age:68±6.74 years,men:72%,and Malay ethnicity:43%).The majority of patients were diagnosed with non-ST-segment elevation acute coronary syndrome(63%),predisposed hypertension(76%)and were overweight(74%),while only 35%of patients underwent percutaneous coronary intervention.Over the five years,there was a significant increasing trend in DAPT prescriptions(P<0.001),with the aspirinclopidogrel combination being the most common.Aspirin-ticagrelor prescriptions have also increased over the years.Variations in DAPT prescriptions were observed based on patient characteristics.Patients who underwent percutaneous coronary intervention were more likely to be prescribed DAPT in general(aOR=2.53,95%CI:1.95–3.28,P<0.001)and aspirin-ticagrelor specifically(aOR=7.76,95%CI:5.65–10.68,P<0.001).Patients with chronic lung disease(aOR=0.62,95%CI:0.42–0.92,P=0.02)and a history of angina within two weeks(aOR=0.69,95%CI:0.56–0.85,P<0.001)were approximately 30%less likely to be prescribed DAPT.Approximately 15%of 1-year all-cause mortality were reported.Older patients prescribed DAPT showed significantly higher survival rates than those who were not(aHR<1.0,P<0.001).Aspirin-ticagrelor was associated with higher survival rates than aspirin-clopidogrel(aHR=0.21,95%CI:0.11–0.40,P<0.001).CONCLUSIONS Despite the optimal prescription rate and variation of DAPT in the older Malaysian population,there is room for investigation and improvement in the prescription of newer DAPT combinations that have been suggested to improve patient survival.展开更多
[Objectives]To observe the clinical effect of Tiaoqi Dingxian prescription combined with western medicine on epilepsy of qi constraint and phlegm stagnation type.[Methods]A total of 60 cases of patients of epilepsy of...[Objectives]To observe the clinical effect of Tiaoqi Dingxian prescription combined with western medicine on epilepsy of qi constraint and phlegm stagnation type.[Methods]A total of 60 cases of patients of epilepsy of qi constraint and phlegm stagnation type admitted to Maoming Hospital Affiliated to Guangzhou University of Chinese Medicine from June 2023 to July 2024 were selected as the research subjects.They were randomly divided into the control group and the observation group using a random number table method,with 30 cases in each group.The control group was treated with levetiracetam,while the observation group was treated with Tiaoqi Dingxian prescription on the basis of the control group.Both groups were treated for 3 months,and the clinical efficacy,frequency and duration of epilepsy onset,improvement of electroencephalogram(EEG),Quality of Life in Epilepsy Inventory(QOLIE-31)scores,traditional Chinese medicine(TCM)syndrome scores,and incidence of adverse reactions were evaluated in both groups.[Results]The total effective rate in the observation group was 93.33%(28/30),compared to 73.33%(22/30)in the control group,with a statistically significant difference(P<0.05).Following treatment,the frequency and duration of epilepsy onset in both groups were decreased when compared to the pre-treatment period(P<0.05),and the frequency and duration of epilepsy onset in the observation group were lower than those in the control group(P<0.05).Following treatment,the EEG grading of both groups was improved when compared with that before treatment(P<0.05),and the EEG grading in the observation group was better than that in the control group(P<0.05).Following treatment,the QOLIE-31 scores in both groups,including epilepsy-related concerns,overall health,emotional health,energy,cognitive function,drug effects,and social function,were increased when compared to the scores recorded prior to treatment(P<0.05),and all scores in the observation group were higher than those in the control group(P<0.05).Following treatment,the TCM syndrome scores in both groups were decreased when compared to those prior to treatment(P<0.05),and the scores in the observation group were lower than those in the control group(P<0.05).The incidence of adverse reactions was observed to be 6.67%(2/30)in the observation group and 13.33%(4/30)in the control group,with no significant difference between the two groups(P>0.05).[Conclusions]The combination of Tiaoqi Dingxian prescription and levetiracetam in the treatment of epilepsy of qi constraint and phlegm stagnation type can improve clinical efficacy,alleviate patient s symptoms and quality of life,and has good safety.展开更多
Objective:Anshen Dingzhi prescription(ADP)is an effective remedy for treating post-traumatic stress disorder(PTSD);however,the mechanism underlying its beneficial effects is unclear.This study explores the roles of th...Objective:Anshen Dingzhi prescription(ADP)is an effective remedy for treating post-traumatic stress disorder(PTSD);however,the mechanism underlying its beneficial effects is unclear.This study explores the roles of the neuroinflammation regulated by the FKBP prolyl isomerase 5(FKBP5)-IκB kinase alpha(IKKα)-nuclear factor kappa-B(NF-κB)-NOD-like receptor thermal protein domain-associated protein 3(NLRP3)signaling pathway in PTSD.Methods:The primary components of ADP,including ginsenosides Rg1 and Rb1,were quantified using ultra-performance liquid chromatography.Twelve C57BL/6 mice were allocated to control(D0)and experimental groups on days one,seven,and 14 of single prolonged stress(SPS).Eighteen C57BL/6 mice were allocated to control,SPS,and MCC950,an NLRP3 inhibitor(5 mg/kg)groups.Finally,24 C57BL/6 mice were allocated to control,SPS,paroxetine hydrochloride(PRX),or ADP(18.4 and 36.8 mg/kg)groups.Mice were administered MCC950,PRX,or ADP for 14 days.The open field test and elevated plus maze were used to evaluate anxiety-like behaviors,whereas fear memory extinction was evaluated using the fear memory test.Western blotting was employed to evaluate the expression levels of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway,tumor necrosis factor-α(TNF-α),interleukin(IL)-6,and IL-1β.The expression of FKBP5 and NLRP3 was further confirmed by immunofluorescence staining.Results:The amounts of ginsenosides Rg1 and Rb1 in ADP were(96.85±1.14)and(9.04±0.22)μg/g,respectively.Compared with the D0 group,the levels of the inflammatory cytokine proteins,TNF-α,IL-6,and IL-1β were elevated 1.33-to 1.51-fold and those of FKBP5-IKKα-NF-κB-NLRP3 signaling pathway were increased 1.16-to 1.41-fold in the hippocampus of the D14 group(P<0.05);the fluorescence intensity of FKBP5 and NLRP3 was also markedly increased(1.33-1.79-fold)in the hippocampus of the D14 group(P<0.5).Notably,injection of MCC950(5 mg/kg)reduced the levels of FKBP5-IKKα-NF-κB-NLRP3(0.80-0.88-fold)and inflammatory cytokines(0.74-0.83-fold),thereby improving the PTSD-like behaviors induced by SPS(P<0.05).In addition,ADP(36.8 g/kg)significantly improved PTSD-like behaviors and reduced levels of hippocampal inflammatory cytokines(0.70-0.79-fold)and FKBP5-IKKα-NF-κB-NLRP3(0.50-0.79-fold)(P<0.05)in SPS mice.Conclusion:The results suggest a potential therapeutic benefit of ADP in PTSD due to the inhibition of the FKBP5-IKKα-NF-κBNLRP3 signaling pathway.展开更多
基金Scientific Research Fund Project of Yunnan Provincial Department of Education(Project No.:2024J2130)。
文摘Objective:To systematically review the current implementation status of nurses’non-pharmacological prescription authority and analyze the barriers encountered during its implementation in China,providing countermeasures and references for promoting the standardized implementation of nurses’non-pharmacological prescription authority.Methods:A secondary analysis of literature was conducted to systematically search for domestic and international literature related to nurses’non-pharmacological prescription authority.Meta-analysis was performed on eligible literature to evaluate the implementation effects.Simultaneously,semi-structured in-depth interviews were conducted with healthcare workers,patients,and policymakers.Content analysis was used to organize the interview data and extract core issues and barriers.Results:A total of 46 international articles were included in the Meta-analysis,which revealed that the implementation of nurses’non-pharmacological prescription authority significantly improved patients’health management outcomes,enhanced healthcare service efficiency,and increased patient satisfaction.Conclusion:The implementation of nurses’non-pharmacological prescription authority has demonstrated significant positive effects.However,China faces multiple barriers in its advancement,necessitating efforts in optimizing policy systems,constructing collaborative models,strengthening professional skills training,and improving social awareness to guide the scientific and rational implementation of nurses’non-pharmacological prescription authority.
文摘Objective:To analyze the application value of prescription management of traditional Chinese medicine formula granules in reducing unreasonable prescriptions.Methods:From January to June 2024,before improving prescription management strategies,118 patients treated with traditional Chinese medicine formula granules were included in the control group.From July to December 2024,after improving prescription management strategies,118 patients treated with traditional Chinese medicine formula granules were included in the observation group.The unqualified prescription rate,incidence of adverse reactions,complaint rate,and satisfaction were compared.Results:The unqualified prescription rate of traditional Chinese medicine formula granules in the observation group was lower than that in the control group(P<0.05);the incidence of adverse reactions and patient complaint rate of traditional Chinese medicine formula granules in the observation group were lower than those in the control group(P<0.05);the satisfaction of traditional Chinese medicine formula granules in the observation group was higher than that in the control group(P<0.05).Conclusion:Improving the prescription management strategy of traditional Chinese medicine formula granules can reduce the unqualified prescription rate and the incidence of adverse drug reactions,reduce patient complaints,and is conducive to improving patient satisfaction.
基金National Multidisciplinary Innovation Team of Traditional Chinese Medicine (ZYYCXTD-D-202204)Science and Technology Project of Haihe Laboratory of Modern Chinese Medicine (22HHZYSS00013)。
文摘Objective Randomized controlled trials(RCTs)of Chinese patent medicines and classic tra-ditional Chinese medicine prescriptions were systematically reviewed from both Chinese and English journals published in 2023.A preliminary summary and evaluation were conducted on the generation and translation of clinical evidence for these treatments.This analysis aims to inform future research on clinical efficacy evaluation and guide the rational application of evidence.Methods RCTs of Chinese patent medicines and classic traditional Chinese prescriptions published in 2023 were comprehensively retrieved from the Artificial Intelligence Clinical Evi-dence Database for Chinese Patent Medicine(AICED-CPM),with supplementary searches conducted in China National Knowledge Infrastructure(CNKI),Wanfang Data,Chinese Sci-ence and Technology Journal Database(VIP),Chinese Biomedical Literature Database(SinoMed),Cochrane Library,PubMed,Embase,and Web of Science.The study characteris-tics and methodological quality of these RCTs were systematically analyzed and evaluated.Results A total of 1443 RCTs of Chinese patent medicines were included,comprising 1399 Chinese articles and 44 English articles.Additionally,334 RCTs of classic traditional Chinese medicine prescriptions were found,with 331 published in Chinese and 3 in English.196567 participants were included,covering 585 types of Chinese patent medicines(487 oral,61 in-jectable,and 37 topical)and 179 classic traditional Chinese medicine prescriptions.The in-volved studies encompassed 22 types of diseases,with research primarily focusing on dis-eases of the circulatory system,the respiratory system,and the genitourinary system.The sample sizes ranged from 18 to 3777 participants,and most studies were conducted at a sin-gle center.Methodologically,the implementation of allocation concealment and blinding re-mained insufficiently emphasized.Conclusion Overall,compared with 2022,both the number of RCT publications and their methodological quality have improved in 2023,with heightened attention to research on diseases of the genitourinary system.However,quality control and standardized management in the design and implementation processes still require enhancement to produce more high-quality clinical evidence and accelerate the translation and application of this evidence.
基金National Major Scientific and the Technological Special Project:Establishment of a Clinically Oriented Preclinical Research and Development Technology Platform for New Chinese Medicines based on Famous Doctors'Prescriptions(No.2017ZX09301011)"Decoding Traditional Chinese Medicine"Project of Beijing University of Chinese Medicine:New Drugs Research and Development of Chinese Medicine based on Famous Doctors and Famous Prescriptions(No.90010961020020)the Horizontal Project:Preclinical Pharmacology and Pharmacodynamic Research of a New Chinese Medicine—Guilong Granules(No.2016110031007799)。
文摘OBJECTIVE:To investigate the protective effects of Guilong prescription(归龙方,GL)on chronic prostatitis(CP)and unravel the underlying mechanisms of its pharmacological effects.METHODS:The composition of GL was determined via linear ion trap/electrostatic field orbital trap tandem highresolution mass spectrometry,and the identified compounds were performed network pharmacological analysis to predict possible pathways of the effects of GL on CP.A CP rat model was established by carrageenan,and rats were randomly assigned into a Control group,Sham group,CP group,GL low dose(3.5 g/kg)group,GL medium dose(7 g/kg)group,and GL high dose(14 g/kg)group.Hematoxylin-eosin staining of the prostate,and prostate blood-perfusion measured by laser speckle contrast analysis were used to evaluate the efficacy of GL.Expression of intercellular cell adhesion molecule-1(ICAM-1)and induce nitric oxide synthase(i NOS)were determined by immunohistochemistry,and the content of interferon-γ(IFN-γ),interleukin-1β(IL-1β),interleukin-4(IL-4),interleukin-10(IL-10),chemokine ligand 1(CXCL1)and tumor necrosis factor-α(TNF-α)were determined by electro-chemiluminescence assays.The expression of p38 mitogen-activated protein kinase(p38 MAPK),phosphatidylinositol 3-kinase(PI3K),ribosomeassociated complex-alpha serine/threonine-protein kinase(Akt),nuclear factor-κ-gene binding p65(NF-κB p65),inhibitor of NF-κB-α(IκBα),glycogen synthase kinase-3β(GSK-3β),and their phosphorylated forms were tested by Western blot.RESULTS:In GL,a total of 48 compounds were identified,including 14 flavonoids,14 alkaloids,11 carboxylic acids,4 lactones,2 glycosides,2 terpenoids and 1 aldehyde.Network pharmacological analysis suggested that the mechanism of GL may be related to PI3K-Akt signaling pathway and cytokine expression.After treatment with GL,inflammatory pathological changes in the prostate of rats were significantly improved,and blood perfusion of the prostate was significantly decreased.GL reduced the expression of IFN-γ,CXCL1,TNF-α,IL-1β,i NOS,ICAM-1,p38 MAPK,p-p38 MAPK,PI3K,p-PI3K,NF-κB,p-NF-κB,IκBα,p-IκBα,GSK-3β,p-GSK-3β,p-Akt in CP rats,and increased the expression of IL-4 and IL-10 in CP rats.CONCLUSION:The chemical compositions of GL were first identified.GL can improve pathological changes in the prostate and recover the prostate blood perfusion of CP rats.The possible mechanisms of GL on CP involve increasing the expression of anti-inflammatory cytokines IL-4 and IL-10,inhibiting pro-inflammatory cytokines TNF-α,IL-1β,and IFN-γ,and down regulating the expression of CXCL1,i NOS,and ICAM-1 via inhibiting PI3K-Akt and NF-κB signaling pathway.
基金Emergency Corona Virus Disease 2019(COVID-19)Response Project of Dongguan:Clinical Efficacy Observation and Mechanism Study of Fuzheng Xuanfei Huashi Formula in the Treatment of COVID-19 Based on the Lingnan Theory of Epidemic Diseases(No.202071715002124)National Natural Science Foundation of China:Study on the Mechanism of Lung Inflammatory Injury Induced by Gut-derived Lipopolysaccharide and Skatole in Spleen Deficiency Animals based on Pulmonary Alveolus Macrophage Heterogeneity(No.82274381)Guangdong Basic and Applied Basic Research Foundation:Development and Industrialization of Traditional Chinese Medicine Classic and Famous Prescription Compound Formulations(No.2021ZD006)。
文摘OBJECTIVE:To determine the effect of Traditional Chinese Medicine(TCM)Fuzheng Xuanfei Huashi prescription(扶正宣肺化湿方,FZXF)on lipopolysaccharide(LPS)-induced pneumonia in mice and identify the mechanism of FZXF in the treatment of LPS-induced lung inflammation.METHODS:The pneumonia model was established by intraperitoneal injection of 5 mg/kg LPS in mice.Cytokines were detected by enzyme-linked immuneosorbent assay(ELISA),macrophages in lung tissue were determined by immunofluorescence,and pathwayrelated data were determined by quantitative real-time polymerase chain reaction(qPCR)and Western blot.RESULTS:The liver,thymus,and spleen index values and the levels of aspartate aminotransferase(AST)and alanine aminotransferase(ALT)obviously increased in LPS-treated mice.FZXF decreased the white blood cell count and reduced the increase in the lung wet weight/dry weight ratio caused by LPS.The hematoxylin-eosin staining result showed that FZXF could maintain the integrity of lung tissue structure,alleviate interstitial oedema and alveolar wall thickening,and reduce inflammatory cell infiltration.Moreover,FZXF markedly reduced the expression of proinflammatory cytokines.FZXF also significantly reduced LPS-induced malondialdehyde production and increased superoxide dismutase level in the lung.By immunofluorescence,we found that FZXF could reduce macrophage infiltration.The mRNA expression levels of cyclooxygenase-2(COX-2),prostaglandin E2(PGE2),toll-like receptor 4(TLR4)and nuclear transcription factorκB(NF-κB)in the lung tissue of mice were decreased by treatment with FZXF.In addition,FZXF inhibited the protein expression of TLR4,p-p65 and COX-2.These results indicated that FZXF could inhibit the inflammatory response of LPS induced cytokine storm in mice through TLR4/NF-κB and COX-2/PGE2 signaling pathway.CONCLUSION:These findings were suggested that FZXF prescription suppresses inflammation in LPSinduced pneumonia in mice via TLR4/NF-κB and COX-2/PGE2 pathway.
基金National Natural Science Foundation of China(91748125)National Administration of Traditional Chinese Medicine’s National Inheritance Studio Construction Project for Famous Veteran Traditional Chinese Medicine Experts([2022]75)。
文摘Objective To configure the complex traditional Chinese medicine(TCM)prescription using digit topology circle and to derive digit topology circle.Methods The basic digit topology circles were constructed.Different digit topology circles were derived using basic digit topology circle,the character strings,and the digit groups.Different digit topology circles with ternary Chinese medicine were derived by adding ternary Chinese medicine into digit topology circles.The valuable TCM prescriptions were configured using the derived digit topology circles.Results Nine simple basic digit topology circles were constructed from the character strings.Multiple digit topology circles and some digit topology circles with ternary Chinese medicine were derived using basic digit topology circles,the character strings,and the digit groups.Four complex TCM prescriptions were configured using four derived digit topology circles digit topology circles,respectively.Conclusion The digit topology circles can be used to configure some existing TCM prescriptions and many novel TCM prescriptions.It has been verified that some existing TCM prescriptions have been used successfully to treat patients with diseases.Some novel valuable TCM prescriptions configured by digit topology circles may be used to treat patients with diseases.
文摘[Objectives]To discuss the curative effect of the external application of self-prepared Chinese prescription decoction combined with gabapentin and cotton moxibustion on postherpetic neuralgia(PHN)and analyze its mechanism.[Methods]96 patients with PHN were divided into the control group(group A)and observation group(group B)(n=48).In group A,the patients were given gabapentin orally and treated by cotton moxibustion.In group B,the patients were treated by the external application of self-prepared Chinese prescription decoction on the basis of the above basic treatment.The total effective rate,apparent time and recurrence rate of the two groups were compared.[Results]The cure rate(72.91%)and total effective rate(95.83%)of patients in group B were higher than those in group A(54.16%,83.33%).The average apparent time[(5.79±1.40)d]and recurrence rate(5.97%)of patients in group B were significantly lower than those in group A[(7.03±4.37)d,10.45%],and the difference between the two groups was statistically significant(P<0.05).[Conclusions]The external application of self-prepared Chinese prescription decoction combined with gabapentin and cotton moxibustion therapy had a significant curative effect and low recurrence rate.
基金supported by the National Natural Science Foundation of China(Grant Nos.:82174259 and 82304997)China Postdoctoral Followship Program of CPSF(Grant No.:GZC20233202)+4 种基金China Postdoctoral Science Foundation(Grant No.:2024M753698)the Key Research and Development Program of Hunan Province of China(Grant Nos.:2023SK2021 and 2022SK2015)the Natural Science Foundation of Hunan Province,China(Grant Nos.:2024JJ6632,2022JJ40853,and 2021JJ31117)the Hunan Traditional Chinese Medicine Scientific Research Program,China(Grant Nos.:B2024113,B2024114,and 2021032)the Fundamental Research Funds for the Central Universities of Central South University,China(Grant No.:1053320232786).
文摘Traditional Chinese medicine(TCM)exerts integrative effects on complex diseases owing to the characteristics of multiple components with multiple targets.However,the syndrome-based system of diagnosis and treatment in TCM can easily lead to bias because of varying medication preferences among physicians,which has been a major challenge in the global acceptance and application of TCM.Therefore,a standardized TCM prescription system needs to be explored to promote its clinical application.In this study,we first developed a gradient weighted disease-target-herbal ingredient-herb network to aid TCM formulation.We tested its efficacy against intracerebral hemorrhage(ICH).First,the top 100 ICH targets in the GeneCards database were screened according to their relevance scores.Then,SymMap and Traditional Chinese Medicine Systems Pharmacology(TCMSP)databases were applied to find out the target-related ingredients and ingredient-containing herbs,respectively.The relevance of the resulting ingredients and herbs to ICH was determined by adding the relevance scores of the corresponding targets.The top five ICH therapeutic herbs were combined to form a tailored TCM prescriptions.The absorbed components in the serum were detected.In a mouse model of ICH,the new prescription exerted multifaceted effects,including improved neurological function,as well as attenuated neuronal damage,cell apoptosis,vascular leakage,and neuroinflammation.These effects matched well with the core pathological changes in ICH.The multi-targets-directed gradient-weighting strategy presents a promising avenue for tailoring precise,multipronged,unbiased,and standardized TCM prescriptions for complex diseases.This study provides a paradigm for advanced achievements-driven modern innovation in TCM concepts.
文摘Objective:To explore the intervention value of the medical institution prescription review mechanism on the rationality of Western medicine use.Methods:A total of 159 patients(with 159 western medicine prescriptions)admitted to the hospital from January 2023 to December 2024 were selected and divided into an observation group(n=80,adopting the medical institution prescription review mechanism)and a control group(n=79,without prescription review)based on the random number table method.A comparative analysis was conducted on the work quality of medical personnel,irrational prescription drug use,and prescription drug dispensing situations.Results:The work quality of medical personnel in the observation group was significantly better than that in the control group(P<0.05).The incidence of irrational prescription drug use in the observation group(22.50%)was significantly higher than that in the control group(7.59%)(P<0.05).The observation group had fewer types of prescribed drugs,lower usage rates of injections and antibiotics,and a significantly higher usage rate of national essential drugs compared to the control group(P<0.05).Conclusion:The prescription review mechanism can significantly improve the work quality of medical personnel,increase the detection rate of irrational drug use,reduce the types of prescription drugs and the use of injections and antibiotics,and promote the standardized application of national essential drugs,which has important intervention value.
基金Supported by the Capital’s Funds for Health Improvement and Research:Clinical Study on Yiqi Liangxue Shengji Prescription for Improving Cardiac Function after Myocardial Ischemia Reperfusion Injury in Patients with Acute Myocardial Infarction(CFH 2020-4-4204)Beijing University of Traditional Chinese Medicine Qihuang Yingcai·Excellent Young Science and Technology Talent Cultivation Program(K2023A03)Beijing University of Traditional Chinese Medicine Dongfang Hospital High-level Capacity Building Project"Zhuoyuan"Project National Talent Precision Cultivation Program(DFRCZY-2024GJRC012)。
文摘OBJECTIVE:To evaluate the effect of Yiqi Liangxue Shengji prescription(益气凉血生肌方,YQLXSJ)on cardiac function and outcomes in acute myocardial infarction(AMI)patients with myocardial ischemiareperfusion injury(MIRI)and to determine its clinical efficacy.METHODS:This prospective,randomized,double-blind,placebo-controlled trial enrolled hospitalized patients with AMI who underwent percutaneous coronary intervention and experienced MIRI either intraoperatively or postoperatively.Participants were randomly allocated to the treatment group,which received YQLXSJ,or the control group,which received a placebo,concurrent with standard Western Medicine therapy.The intervention period lasted 8 weeks.The primary outcome measure was left ventricular ejection fraction(LVEF),determined by echocardiography.Secondary outcomes included Nterminal pro brain natriuretic peptide(NT-pro BNP)and cardiac troponin I(cTnI)levels,left ventricular internal diameter,major adverse cardiovascular events(MACE),angina pectoris scores,and Chinese medicine evidence scores.RESULTS:Following 8 weeks of intervention,the treatment group demonstrated a significant increase in LVEF and a marked reduction in NT-pro BNP when compared to the control group.There was also a significant decrease in peak cTnI levels,Chinese medicine evidence scores,and angina pectoris scores.The control group's left ventricular end-systolic diameter(LVESD)significantly increased compared to baseline after 8 weeks(P<0.05),whereas the treatment group's LVESD showed no significant change from baseline(P>0.05).Although the treatment group showed a downward trend in MACE incidence compared to the control group,this difference was not statistically significant(P>0.05).CONCLUSIONS:This study demonstrated that the addition of YQLXSJ to standard therapy can improve cardiac function and alleviate clinical symptoms in AMI patients with MIRI,and also showed a potential to mitigate the incidence of MACE.Furthermore,YQLXSJ displayed a favorable safety profile in clinical application.
基金Supported by Jiangsu Postgraduate Research and Practice Innovation Programme,No.KYCX24_2242Science and Technology Project of Jiangsu Provincial Hospital of Traditional Chinese Medicine,No.Y22002Forth Batch of Construction Program for Inheritance Office of Jiangsu Province Famous Traditional Chinese Medicine Experts,No.[2021]7.
文摘BACKGROUND Xietu Hemu prescription(XHP),a Chinese patent formula,is optimized based on the theory of“phlegm-dampness”and has been clinically validated to effectively combat metabolic dysfunction-associated steatotic liver disease(MASLD).It notably reduces visceral fat and body mass index.However,the molecular mechanisms underlying its regulation of lipid metabolism homeostasis remain unexplored.AIM To elucidate the mechanisms by which XHP inhibits adipocyte differentiation and maintains lipid metabolism homeostasis.METHODS The therapeutic efficacy of XHP in metabolic-related disorders was analyzed using HepG2 cells and 3T3-L1 cells,along with transcriptomics to assess gene expression alterations during white adipogenesis.The primary metabolites of XHP were identified through ultra-performance liquid chromatography,and metabolic pathways were examined via serum metabolomics.Network analysis was employed to predict therapeutic targets.The accumulation of lipid droplets and the expression of associated proteins were confirmed using oil red O staining and Western blotting,respectively.Molecular docking was utilized to identify core targets and signaling pathways,which were substantiated through immunofluorescence and siRNA interference.RESULTS XHP-containing serum(XHPS)significantly inhibited the transformation of normal HepG2 cells into fatty liver cells.Concurrently,the treatment suppressed the differentiation of 3T3-L1 cells,reduced lipid droplet accumulation and total cholesterol/triglyceride levels,and downregulated the expression of PPARγ,C/EBPα,and FABP4.Through transcriptomics and network pharmacological intersectionality analyses,24 core targets were identified,predominantly enriched in the AMPK signaling pathway.Molecular docking validated the strong binding affinity of XHP metabolites to targets such as leptin(-11.3 kcal/mol)and ADIPOQ(-9.4 kcal/mol).ELISA results indicated that XHPS augmented leptin autocrine secretion,thereby activating the AMPK signaling pathway(P<0.05).Conversely,LEPR knockdown negated this effect(P<0.05).CONCLUSION XHP effectively inhibits adipogenesis and enhances lipid metabolism homeostasis through the LEP/AMPK/PPARγpathway,presenting a promising multi-target therapeutic strategy for MASLD by mitigating lipotoxicity.
基金National Natural Science Foundation of China:Exploring the Mechanism of Improved Yupingfeng Powder in Treating Allergic Rhinitis Based on the Nucleotide-Binding Oligomerization Domain,Leucine-rich Repeat and Pyrin Domain-containing Protein 3/Interleukin-33-Mediated Activation Pathway of Pulmonary Group 2 Innate Lymphoid Cells in Airway Epithelial Cells(No.82374526)Science and Technology Project of Guangzhou:Mechanism of Shikonin in Treating Acute Lung Injury Through Regulating M1 Macrophage Polarization via Adenosine 5'-monophosphate-Activated Protein Kinase/Dynamin-Related Protein 1-mediated Mitochondrial Dynamics(No.2024A04J4334)+2 种基金Exemplary Study on Process Optimization and Quality Standard Enhancement of Hospital Preparations Such as Gangmei Qingyan Mixture(No.2023A03J0299)Anti-Allergic Mechanism of Improved Yupingfeng Powder in Alleviating Nasal Mucosal Inflammation in Allergic Rhinitis via Interleukin-33/Suppression of Tumorigenicity 2-Regulated Group 2 Innate Lymphoid Cells Suppression(No.202201020457)Elite Talent Program of the First Affiliated Hospital of Guangzhou University of Chinese Medicine by 2023 Years and Guangdong Province Lingnan Characteristic Hospital Preparation Transformation Engineering Technology Research Center(No.2023A170)。
文摘OBJECTIVE:To identify the main active ingredients of Improved Yupingfeng Powder prescription(IYPFP,玉屏风散加味)and investigate its anti-inflammatory effects and underlying mechanisms in ovalbumins(OVA)-induced allergic rhinitis(AR)in mice.METHODS:Bagg Albino/substrain mice were sensitized with OVA emulsified in aluminum hydroxide adjuvant,followed by intranasal challenge to establish AR models.Treatment groups received IYPFP(1.5 or 4.5 g/kg)via daily gavage for 14 d.The nasal mucosa tissues were collected for pathological observation.The expression of OVA-specific immunoglobulin E(Ig E),histamine,and interleukin-33(IL-33)was detected by enzyme-linked immunosorbent assay.IL-5,IL-13,IL-33,suppression of tumorigenicity 2(ST2),tumor necrosis factor-α(TNF-α)and interferon-γ(IFN-γ)in the nasal mucosa and lung were detected by quantitative polymerase chain reaction and Western blot.High performance liquid chromatography and ultra-high performance liquid chromatography quadrupole exactive orbitrap mass spectrometry were used to detect the chemical fingerprints of IYPFP,and the chemical compositions of plasma from rats treated with IYPFP at 0.5,1,1.5,2,3,4 and 6 h,respectively.Virtual screening of bioactive compounds was conducted through molecular docking targeting IL-33/ST2 pathway proteins.RESULTS:Eight chemical compounds of IYPFP were accurately identified,they are prim-O-glucosylcimifugin(peak 2),calycosin-7-O-β-D-glucoside(peak 4),cimifugin(peak 5),5-O-methylvisammioside(peak 6),sec-Oglucosylhamaudol(peak 12),calycosin(peak 15),formononetin(peak 19),and magnolin(peak 21).Compared with the OVA model group,IYPFP alleviated the nasal symptoms,improved nasal mucosal injury and downregulated the levels of OVA-specific Ig E,histamine and IL-33.Additionally,IYPFP reduced the levels of IL-5,IL-13,TNF-α,IL-33,and ST2 in the lungs,but upregulated IFN-γ.Molecular docking confirmed that eight representative compounds of IYPFP had good binding properties with IL-5,IL-13,IFN-γ,histamine,IL-33 and ST2,and were able to inhibit the activation of the IL33/ST2 inflammatory pathway.CONCLUSION:This study demonstrates that IYPFP ameliorates AR by modulating IL-33/ST2 pathway which provides a theoretical basis for the clinical treatment of patients with AR.
基金supported by the Project of LI Ruiyu National Famous Traditional Chinese Medicine Expert Inheritance Studio(No.[2022]4 issued by the National Administration of Traditional Chinese Medicine and No.[2024]3 issued by Hebei Administration of Traditional Chinese Medicine)the Seventh Batch of National Academic Experience Inheritance Project for Senior Traditional Chinese Medicine Experts(No.[2022]76 issued by the National Administration of Traditional Chinese Medicinethe Scientific Research Project of Hebei Administration of Traditional Chinese Medicine(No.2025593).
文摘Objectives:To propose a new idea of“lung ventilation and Qi regulation”for preventing and treating lung cancer,and to summarize the corresponding Tongfei Huajie prescription,as a systematic theoretical and practical innovation.Methods:Based on the etiology and pathogenesis of lung cancer,the anatomy,physiology and pathology of the lung,and inspired by the ancient“Tuoyue”(bellows)theory,this study combined the clinical observation of ventilation issues in lung cancer patients.The Tongfei Huajie prescription was formulated following the classic principle of monarch(Jun),minister(Chen),assistant(Zuo),and guide(Shi),and was interpreted with modern pharmacological research.Results:A novel therapeutic concept of“lung ventilation and Qi regulation”was proposed.The corresponding Tongfei Huajie prescription was developed,which has the effects of ventilating the lung,expelling phlegm dampness,tonifying Qi,tonifying the kidney and spleen for lung health,soothing the liver and descending lung Qi,and clearing the heart and moistening the lung.Clinical application has achieved obvious curative effect.Conclusions:This work presents a systematic summary of the innovation in“theory,method,formula and herb”for lung cancer treatment,demonstrating the advantages of Traditional Chinese Medicine in this field.
文摘[Objectives]This study was conducted to analyze the medication laws of traditional Chinese medicine prescriptions for the treatment of spleen-deficiency irritable bowel syndrome in Guanling Autonomous County Hospital of Traditional Chinese Medicine.[Methods]Prescriptions for the treatment of spleen-deficiency irritable bowel syndrome(IBS)were retrieved from the TCM family of the hospital,traditional Chinese medical doctor Wu Zhongli,in the period from November 2023 to April 2024.Microsoft Excel 2007 was employed to set up an information table of TCM prescriptions,and the age,gender,herbal properties,efficacy categories and the frequency of use were analyzed to explore the medication laws of TCM in the hospital for the treatment of spleen-deficiency irritable bowel syndrome.[Results]Among the 259 TCM prescriptions included,152 kinds of TCM decoction pieces were used.The decoction pieces were mainly warm in nature,and decoction pieces cold in nature took the second place.The flavors of the herbs were mostly sweet,bitter and pungent.Most of them were attributive to the spleen,stomach meridian and lung meridians,and the herbs were mainly used for tonifying deficiency and regulating qi.The herbs with higher frequency of use included Radix Glycyrrhiza,Pericarpium Citri Reticulatae,poria,and Angelicae Sinensis Radix,the main effects of which are replenishing qi to invigorate the spleen,activating qi and eliminating phlegm,clearing damp and promoting diuresis,and relaxing bowel.[Conclusions]Chinese medicine treatment of IBS with spleen deficiency in hospitals is mainly based on replenishing qi to invigorate the spleen,activating qi and eliminating phlegm,clearing damp and promoting diuresis,and relaxing bowel,and Xiangsha Liujunzi Decoction is commonly used in clinical treatment based on syndrome differentiation with modifications.
基金the Guangxi Science and Technology Major Project/Program,China(Grant Nos.:GUIKEAA22096029,GUIKEAA23023035)State Key Laboratory of Drug Regulatory Science Project,National Institutes for Food and Drug Control(NIFDC),China(Grant No.:2024SKLDRS0101)+1 种基金Shanghai Institute of Material Medical(SIMM)-National EngineeringResearch Center of TCM Standardization Technology Independent Research Program,Chinathe staff members of the Large-scale MS System at the National Facility for Protein Science in Shanghai(NFPs),Zhangjiang Lab,China for providing technical support.
文摘The quality of traditional Chinese medicine(TCM)prescriptions(TCMPs)is critical to clinical efficacy;however,evaluating their consistency and identifying sources of variability remain challenging.This study proposes an integrated strategy to assess the quality of 100 widely sold TCMPs.A"one-for-all"chromatographic method was employed to analyze 645 sample batches.This large-scale data collection enabled statistical evaluations,such as hierarchical cluster analysis(HCA)and similarity heatmap,to identify quality inconsistencies.The introduction of a TCM-specific mass spectrometry(MS)database allowed for rapid,automated annotation of chemicals across 100 prescriptions and facilitated the tracing of raw material sources.Results indicate that 19%of prescriptions exhibited chemical inconsistencies,which are associated with high market value,low pricing,and substantial price disparities.The MS database allowed rapid annotation of 761 and 673 compounds in positive and negative modes,respec-tively,in 100 TCMPs,with 73 prescriptions reported for the first time.The tracing efforts succeeded in identifying>40%of the raw material sources for 51 prescriptions.P93(Yinianjin(YNJ))is a case in which the chromatographic profiles from three manufacturers displayed inconsistencies.Analysis using the database traced divergent peaks to Rhei Radix et Rhizoma(RRER).Verification with self-prepared samples confirmed that manufacturers utilized three distinct botanical sources.This integrated strategy provides a scalable framework for quality control in TCMPs.
基金supported by the Ministry of Science and Technology of the People’s Republic of China under the“New Generation Artificial Intelligence”Major Project of Science and Technology Innovation 2030(2020AAA0105002).
文摘Irrational drug use and prescription safety are pressing global concerns.The World Health Organization estimated that over half of all prescriptions worldwide contain errors,leading to substantial harm[1,2].In China,prescription errors occur at a rate of 32%,and improper medication use is reported in over 70%of households[3,4].Vulnerable populations,including children(16.7%)and older adults(30.4%),are particularly affected[5].
文摘This article provides a comprehensive review of the advancements in the application of artificial intelligence(AI)technology in the modernization of traditional Chinese medicine(TCM)compound prescriptions,and emphasizes recent research developments,including intelligent design,prediction of mechanisms of action,and precise application of TCM compound prescriptions.The integration of multi-omics data,deep learning algorithms,and knowledge graph technologies has established novel technical avenues for the modernization research of TCM.This study systematically analyzes the advantages and challenges associated with AI technologies in the research of TCM compound prescriptions,highlighting issues such as data heterogeneity,limited interpretability of AI models,and the absence of standardized procedures.Furthermore,this article examines the prospective developmental trajectories within this field,highlighting the importance of synergistic collaboration between AI and traditional pharmacology to improve the clinical applicability and effectiveness of TCM.The objective is to offer valuable insights into the modernization of TCM driven by AI and to stimulate further research in this area.
文摘OBJECTIVES To examine 5-year trends and variations in dual antiplatelet therapy(DAPT)prescription among multiethnic Malaysian patients aged 60 years and older.METHODS Using the Malaysian National Cardiovascular Disease-Acute Coronary Syndrome(NCVD-ACS)registry,DAPT 5-year temporal trends prescribing patterns at discharge were examined.Multivariate logistic regression was used to calculate the adjusted odds ratio(aOR)of DAPT prescription.The 1-year all-cause mortality by Cox proportional hazard regression model(adjusted hazard ratio,aHR)using inverse proportional weighting covariates adjustment was performed to assess DAPT prognostic impacts.RESULTS Data of patients aged 60 years and older were extracted from 2013 to 2017(n=3718,mean age:68±6.74 years,men:72%,and Malay ethnicity:43%).The majority of patients were diagnosed with non-ST-segment elevation acute coronary syndrome(63%),predisposed hypertension(76%)and were overweight(74%),while only 35%of patients underwent percutaneous coronary intervention.Over the five years,there was a significant increasing trend in DAPT prescriptions(P<0.001),with the aspirinclopidogrel combination being the most common.Aspirin-ticagrelor prescriptions have also increased over the years.Variations in DAPT prescriptions were observed based on patient characteristics.Patients who underwent percutaneous coronary intervention were more likely to be prescribed DAPT in general(aOR=2.53,95%CI:1.95–3.28,P<0.001)and aspirin-ticagrelor specifically(aOR=7.76,95%CI:5.65–10.68,P<0.001).Patients with chronic lung disease(aOR=0.62,95%CI:0.42–0.92,P=0.02)and a history of angina within two weeks(aOR=0.69,95%CI:0.56–0.85,P<0.001)were approximately 30%less likely to be prescribed DAPT.Approximately 15%of 1-year all-cause mortality were reported.Older patients prescribed DAPT showed significantly higher survival rates than those who were not(aHR<1.0,P<0.001).Aspirin-ticagrelor was associated with higher survival rates than aspirin-clopidogrel(aHR=0.21,95%CI:0.11–0.40,P<0.001).CONCLUSIONS Despite the optimal prescription rate and variation of DAPT in the older Malaysian population,there is room for investigation and improvement in the prescription of newer DAPT combinations that have been suggested to improve patient survival.
文摘[Objectives]To observe the clinical effect of Tiaoqi Dingxian prescription combined with western medicine on epilepsy of qi constraint and phlegm stagnation type.[Methods]A total of 60 cases of patients of epilepsy of qi constraint and phlegm stagnation type admitted to Maoming Hospital Affiliated to Guangzhou University of Chinese Medicine from June 2023 to July 2024 were selected as the research subjects.They were randomly divided into the control group and the observation group using a random number table method,with 30 cases in each group.The control group was treated with levetiracetam,while the observation group was treated with Tiaoqi Dingxian prescription on the basis of the control group.Both groups were treated for 3 months,and the clinical efficacy,frequency and duration of epilepsy onset,improvement of electroencephalogram(EEG),Quality of Life in Epilepsy Inventory(QOLIE-31)scores,traditional Chinese medicine(TCM)syndrome scores,and incidence of adverse reactions were evaluated in both groups.[Results]The total effective rate in the observation group was 93.33%(28/30),compared to 73.33%(22/30)in the control group,with a statistically significant difference(P<0.05).Following treatment,the frequency and duration of epilepsy onset in both groups were decreased when compared to the pre-treatment period(P<0.05),and the frequency and duration of epilepsy onset in the observation group were lower than those in the control group(P<0.05).Following treatment,the EEG grading of both groups was improved when compared with that before treatment(P<0.05),and the EEG grading in the observation group was better than that in the control group(P<0.05).Following treatment,the QOLIE-31 scores in both groups,including epilepsy-related concerns,overall health,emotional health,energy,cognitive function,drug effects,and social function,were increased when compared to the scores recorded prior to treatment(P<0.05),and all scores in the observation group were higher than those in the control group(P<0.05).Following treatment,the TCM syndrome scores in both groups were decreased when compared to those prior to treatment(P<0.05),and the scores in the observation group were lower than those in the control group(P<0.05).The incidence of adverse reactions was observed to be 6.67%(2/30)in the observation group and 13.33%(4/30)in the control group,with no significant difference between the two groups(P>0.05).[Conclusions]The combination of Tiaoqi Dingxian prescription and levetiracetam in the treatment of epilepsy of qi constraint and phlegm stagnation type can improve clinical efficacy,alleviate patient s symptoms and quality of life,and has good safety.
基金supported by the National Natural Science Foundation of China(82404995,82404890)Research Funds of Center for Xin’an Medicine and Modernization of Traditional Chinese Medicine of IHM(2023CXMMTCM013)+3 种基金Scientific Research Program of Anhui Provincial Department of Education(2024AH051036,2024AH040137,2024AH051044)Excellent Funding for Academic and Scientific Research Activities for Academic and Technological Leaders in Anhui Province(2022D317)Key Research and Development Plan of Anhui Province(202104j07020004)Anhui University of Chinese Medicine Talent Support Program(DT2300000173).
文摘Objective:Anshen Dingzhi prescription(ADP)is an effective remedy for treating post-traumatic stress disorder(PTSD);however,the mechanism underlying its beneficial effects is unclear.This study explores the roles of the neuroinflammation regulated by the FKBP prolyl isomerase 5(FKBP5)-IκB kinase alpha(IKKα)-nuclear factor kappa-B(NF-κB)-NOD-like receptor thermal protein domain-associated protein 3(NLRP3)signaling pathway in PTSD.Methods:The primary components of ADP,including ginsenosides Rg1 and Rb1,were quantified using ultra-performance liquid chromatography.Twelve C57BL/6 mice were allocated to control(D0)and experimental groups on days one,seven,and 14 of single prolonged stress(SPS).Eighteen C57BL/6 mice were allocated to control,SPS,and MCC950,an NLRP3 inhibitor(5 mg/kg)groups.Finally,24 C57BL/6 mice were allocated to control,SPS,paroxetine hydrochloride(PRX),or ADP(18.4 and 36.8 mg/kg)groups.Mice were administered MCC950,PRX,or ADP for 14 days.The open field test and elevated plus maze were used to evaluate anxiety-like behaviors,whereas fear memory extinction was evaluated using the fear memory test.Western blotting was employed to evaluate the expression levels of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway,tumor necrosis factor-α(TNF-α),interleukin(IL)-6,and IL-1β.The expression of FKBP5 and NLRP3 was further confirmed by immunofluorescence staining.Results:The amounts of ginsenosides Rg1 and Rb1 in ADP were(96.85±1.14)and(9.04±0.22)μg/g,respectively.Compared with the D0 group,the levels of the inflammatory cytokine proteins,TNF-α,IL-6,and IL-1β were elevated 1.33-to 1.51-fold and those of FKBP5-IKKα-NF-κB-NLRP3 signaling pathway were increased 1.16-to 1.41-fold in the hippocampus of the D14 group(P<0.05);the fluorescence intensity of FKBP5 and NLRP3 was also markedly increased(1.33-1.79-fold)in the hippocampus of the D14 group(P<0.5).Notably,injection of MCC950(5 mg/kg)reduced the levels of FKBP5-IKKα-NF-κB-NLRP3(0.80-0.88-fold)and inflammatory cytokines(0.74-0.83-fold),thereby improving the PTSD-like behaviors induced by SPS(P<0.05).In addition,ADP(36.8 g/kg)significantly improved PTSD-like behaviors and reduced levels of hippocampal inflammatory cytokines(0.70-0.79-fold)and FKBP5-IKKα-NF-κB-NLRP3(0.50-0.79-fold)(P<0.05)in SPS mice.Conclusion:The results suggest a potential therapeutic benefit of ADP in PTSD due to the inhibition of the FKBP5-IKKα-NF-κBNLRP3 signaling pathway.
